GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Klaria Pharma Holding AB (STU:6FN) » Definitions » Institutional Ownership

Klaria Pharma Holding AB (STU:6FN) Institutional Ownership : 0.02% (As of Mar. 30, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Klaria Pharma Holding AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Klaria Pharma Holding AB's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Klaria Pharma Holding AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Klaria Pharma Holding AB's Float Percentage Of Total Shares Outstanding is 0.00%.


Klaria Pharma Holding AB Institutional Ownership Historical Data

The historical data trend for Klaria Pharma Holding AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Klaria Pharma Holding AB Institutional Ownership Chart

Klaria Pharma Holding AB Historical Data

The historical data trend for Klaria Pharma Holding AB can be seen below:

2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31
Institutional Ownership 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.02

Klaria Pharma Holding AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Klaria Pharma Holding AB Business Description

Traded in Other Exchanges
Address
Virdings Alle 2, Uppsala, SWE, 754 50
Klaria Pharma Holding AB is engaged in the development and commercialization of pharmaceutical products in Sweden for migraine and cancer-related pain. Its operations are based on a patented drug delivery platform in the form of an alginate-based polymer film. Majority of the group's operations are conducted in Sweden.

Klaria Pharma Holding AB Headlines

No Headlines